|
|
Journal of Obstetrics, Gynecology and Cancer Research، جلد ۲، شماره ۴، صفحات ۰-۰
|
|
|
| عنوان فارسی |
|
|
| چکیده فارسی مقاله |
|
|
| کلیدواژه‌های فارسی مقاله |
|
|
| عنوان انگلیسی |
Intraperitoneal Chemotherapy in Ovarian Cancer |
|
| چکیده انگلیسی مقاله |
Epithelial ovarian cancer (EOC) is the fifth leading cause of cancer death in women. Primary surgery, followed by adjuvant chemotherapy is the basis of treatment for this disease. A standard treatment includes primary surgery and if possible optimal debulking surgery (tumor residue of < 1 cm), followed by a chemotherapy; paclitaxel-carboplatin is the standard regimen in ovarian cancer. Given that the main method of spreading this disease is in the peritoneal cavity, the systemic chemotherapy brings about numerous complications; moreover, as the method of prescribing a drug inside the peritoneum causes a high drug concentration in the peritoneal cavity, conducting an intraperitoneal chemotherapy has been examined clinically. In cases of ovarian cancer recurrence, performing a secondary cytoreductive surgery, in addition to hyperthermic intraperitoneal chemotherapy (HIPEC), has led to a good survival among patients. Currently, studies are ongoing to better explain the effects of this treatment method compared to previous methods. |
|
| کلیدواژه‌های انگلیسی مقاله |
Epithelial Ovarian Cancer,Intraperitoneal Chemotherapy,HIPEC |
|
| نویسندگان مقاله |
|
|
|
|
|
|
|
|
| نشانی اینترنتی |
http://jogcr.com/en/articles/64177.html |
| فایل مقاله |
اشکال در دسترسی به فایل - ./files/site1/rds_journals/2660/article-2660-585354.pdf |
| کد مقاله (doi) |
10.5812/jogcr.64177 |
| زبان مقاله منتشر شده |
|
| موضوعات مقاله منتشر شده |
|
| نوع مقاله منتشر شده |
Review Article |
|
|
|
برگشت به:
صفحه اول پایگاه |
نسخه مرتبط |
نشریه مرتبط |
فهرست نشریات
|